Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol. 2019;17(1):33–58. https://doi.org/10.2174/1570159x16666180917105033.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72(11):1304–12. https://doi.org/10.1001/jamaneurol.2015.2378.

Article  PubMed  Google Scholar 

Mitoma H, Manto M, Hadjivassiliou M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord. 2021;14(1):10–28. https://doi.org/10.14802/jmd.20040.

Article  PubMed  PubMed Central  Google Scholar 

Hadjivassiliou M, Boscolo S, Tongiorgi E, Grünewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord. 2008;23(10):1370–7. https://doi.org/10.1002/mds.22129.

Article  PubMed  Google Scholar 

Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an International Task Force on immune-mediated cerebellar ataxias. Cerebellum (London, England). 2020;19(4):605–10. https://doi.org/10.1007/s12311-020-01132-8.

Article  PubMed  PubMed Central  Google Scholar 

Jarius S, Wildemann B. ‘Medusa-head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015;12:166. https://doi.org/10.1186/s12974-015-0356-y.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015;12:167. https://doi.org/10.1186/s12974-015-0357-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:168. https://doi.org/10.1186/s12974-015-0358-9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Masi G, Spagni G, Campetella L, Monte G, Sabatelli E, Evoli A, et al. Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis. Journal of neuroimmunology. 2021;356:577601. https://doi.org/10.1016/j.jneuroim.2021.577601.

Article  PubMed  CAS  Google Scholar 

Lee SK, Lee ST. The laboratory diagnosis of autoimmune encephalitis. J Epilepsy Res. 2016;6(2):45–50. https://doi.org/10.14581/jer.16010.

Article  PubMed  PubMed Central  Google Scholar 

Hadjivassiliou M, Grunewald RA, Shanmugarajah PD, Sarrigiannis PG, Zis P, Skarlatou V, et al. Treatment of primary autoimmune cerebellar ataxia with mycophenolate. Cerebellum (London, England). 2020;19(5):680–4. https://doi.org/10.1007/s12311-020-01152-4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hadjivassiliou M, Grϋnewald RA. Gluten ataxia: an underdiagnosed condition. The Cerebellum. 2022;21(4):620–2. https://doi.org/10.1007/s12311-021-01270-7.

Article  PubMed  Google Scholar 

Guan WJ, Liu XJ, Tang BS, Liu YT, Zhou Y, Jiang H, et al. Gluten ataxia of sporadic and hereditary cerebellar ataxia in patients from mainland China. Neurol India. 2013;61(3):226–30. https://doi.org/10.4103/0028-3886.115056.

Article  PubMed  Google Scholar 

Liu M, Ren H, Zhu Y, Fan S, Bai L, Wang J, et al. Autoimmune cerebellar ataxia: etiology and clinical characteristics of a case series from China. The Cerebellum. 2022. https://doi.org/10.1007/s12311-022-01412-5.

Article  PubMed  Google Scholar 

Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, et al. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63–7. https://doi.org/10.1016/j.jneuroim.2018.04.001.

Article  PubMed  CAS  Google Scholar 

Ruiz-García R, Martínez-Hernández E, Joubert B, Petit-Pedrol M, Pajarón-Boix E, Fernández V, et al. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2. Neurol (R) Neuroimmunol Neuroinflammation. 2020;7(2):e658. https://doi.org/10.1212/nxi.0000000000000658.

Article  Google Scholar 

Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum & ataxias. 2015;2:14. https://doi.org/10.1186/s40673-015-0034-y.

Article  Google Scholar 

Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol. 2013;15(2):185–200. https://doi.org/10.1007/s11940-012-0215-4.

Article  PubMed  PubMed Central  Google Scholar